ClinicalTrials.Veeva

Menu

Study of Nasal Mucosa Histopathological Changes in Chronic Hypersensitivity Pneumonitis

Cairo University (CU) logo

Cairo University (CU)

Status

Completed

Conditions

Hypersensitivity Pneumonitis
Nasal Mucosal Disorder

Treatments

Procedure: nasal endoscopy

Study type

Interventional

Funder types

Other

Identifiers

NCT05723796
MD-138-2021

Details and patient eligibility

About

Background:Hypersensitivity pneumonitis (HP) is an interstitial lung disease that develops after inhalation of organic or inorganic antigens in susceptible individuals. The nasal mucosa is constantly exposed to these antigens that can irritate the respiratory mucosa.

Objectives: to assess the burden of sinonasal symptoms in HP patients and to evaluate the nasal histopathology in those patients.

Enrollment

40 patients

Sex

All

Ages

29 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • all patients with clinical and radiological features of HP

Exclusion criteria

  • respiratory failure
  • patients on anticoagulants

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

40 participants in 1 patient group

chronic HP patients
Experimental group
Treatment:
Procedure: nasal endoscopy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems